Glioblastoma and Individualized Therapies

Zentrum fur Humangenetik Tuebingen

Status

Conditions: Glioma, Malignant

Treatments: Biological: Vaccination

Study type: Expanded Access

Funder types: Other

Identifiers

NCT05356312

GBM-RWD

Details and patient eligibility

About

The treatment of patients with World Health Organization (WHO) grade 4 malignant glioma has not seen any significant breakthrough the past years. Following surgery and radio / chemotherapy patients still experience a very high recurrence risk and the prognosis is dismal. The investigators observed patients with grade IV malignant glioma receiving individualized treatment based on their molecular profile including fully personalized vaccines.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• malignant glioma, IDH WT

Exclusion criteria

• na